Our 3 R&D Centers are dedicated to exploring innovative medical solutions.
SYMATESE R&D department is fully integrated from design to production, including regulatory support.
Every year, our innovative medical devices, combined with our delivery systems, are used by specialized practitioners, and make it possible to treat more than 25 million patients worldwide per year. These products are created, developed and manufactured within 4 entities that operate our various technological platforms including tissue reconstruction and regeneration, inspired by nature, for various specialties, mostly surgical: plastic, reconstructive and aesthetic, cardiac and vascular, ophthalmic, orthopedic and rheumatological, dental and maxillofacial.
In close collaboration with its partners, SYMATESE manages:
- The methodological tool
A structured project schedule, including:
» Book of technical requirements
» IP Strategy
Integrated Innovation Process
SYMATESE’s Research & Development department is experienced and skilled to handle the design of new products with creativity and efficiency in an adapted and controlled quality environment.
Its offer is fully integrated from design to production and regulatory support.
SYMATESE’s experience in biopolymer transformation and medical device design, combined with its agility, allow for an optimized cost and time to market.
The partnership is managed by a tailor-made contract covering the relation from the design to the production phase to secure the partnership on the long run. We dedicate more than 17 % of our turnover to Research & Development every year in order to develop new and innovative MetTech solutions.
SYMATESE develops innovative and safe technical solutions to accurately meet the needs and expectations of patients in health and quality of life improvement. These solutions also meet quality and regulatory requirements.
Creativity, methodological tools and project management is day to day practice to optimise time to market and regulatory strategy.
The Research and Development team is a strong multidisciplinary team of experienced doctors, engineers and technicians from different science disciplines such as chemistry, biochemistry, biomaterials, biology, and pharmacy. It comprises 10 people, and is internally supported by an analytical laboratory and an industrialisation team.
The R&D team matches biopolymer and plastic injection science with their medical application to design efficient and innovative medical devices. The team works in close collaboration with surgeons, physicians and practitioners to develop innovative products meeting the needs of both the user and patients.
Intellectual Property Policy
Acquisition and maintenance of effective IP rights is a key objective for R&D.
- IP strategy is fully integrated in SYMATESE’s approach for design & development allowing SYMATESE to own a consistent and wide IP portfolio,
- SYMATESE possesses trademarks for its own products,
- SYMATESE is also deeply involved in worldwide patent strategy development for innovative products and process protection.
In early development stages, SYMATESE carries out research and state of the art analysis to provide a clarified view of patent opportunity and freedom to operate (FTO). Once opportunity is identified, a patent is written and filed. SYMATESE currently owns nine patent families.
Internally, it is SYMATESE’s policy to involve regulatory affairs, production and marketing, from the early phase of development and through the entire development process.
The development of public and private partnerships allows SYMATESE to offer ever more innovative solutions.
SYMATESE is also involved in projects funded by the French National Agency for Research (ANR).
SYMATESE is accredited by the French Ministry of Research and higher education as a research and development centre (CRO) for R&D Tax Credit.